Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've come across the name Viogen tirzepatide while researching weight-loss injections, you're not alone. Viogen Pharmaceuticals is a manufacturer that produces tirzepatide, the active medicine in Mounjaro — the dual GIP and GLP-1 receptor agonist licensed in the UK for weight management. In the UK, tirzepatide is only legally available under the Mounjaro brand, supplied through the licensed UK supply chain, and only on a valid prescription issued after clinical assessment. If you've seen Viogen-labelled tirzepatide offered online without that route, it's worth reading this page carefully before going any further.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've been reading about Mounjaro, you've seen the results people get, and then a search brings up something labelled Viogen tirzepatide at a price that looks much more appealing. It's easy to assume it's the same thing in different packaging. The chemistry is the same active molecule (tirzepatide) but the legal situation is not.
Viogen Pharmaceuticals is a manufacturer of tirzepatide. In some markets outside the UK, tirzepatide products from different manufacturers may be licensed and supplied through regulated channels. In the UK, however, the only tirzepatide product that holds a marketing authorisation from the MHRA is Mounjaro, made by Eli Lilly. That authorisation is what allows a UK pharmacy to legally dispense the medicine. A product without UK marketing authorisation hasn't been assessed for quality, safety and efficacy by the UK regulator, regardless of what the active ingredient label says.
This matters more than it might seem. The MHRA has warned repeatedly about counterfeit and unlicensed weight-loss medicines circulating online, including fake pens that have contained entirely the wrong substances. Buying outside the licensed supply chain removes every safety check that sits between manufacturing and your body. If you want to read more about Viogen Pharmaceuticals and tirzepatide specifically, that page goes into more detail about the company and its products.
In the UK, tirzepatide comes as a once-weekly subcutaneous injection in a pre-filled KwikPen, in strengths from 2.5mg up to 15mg. Treatment starts at the lowest strength while your system adjusts, then is titrated by your prescriber over several weeks. The pen that arrives from a GPhC-registered pharmacy will carry Eli Lilly's Mounjaro branding, full UK-language patient information, and a batch number traceable through the licensed supply chain.
Getting it legally means going through a clinical assessment with a prescriber, someone who checks your medical history, current medicines, BMI and overall health before deciding whether tirzepatide is appropriate for you. That step isn't a formality. It's what catches the contraindications: a history of pancreatitis, certain thyroid conditions, specific medications that interact, or a clinical picture where a different approach makes more sense.
The NICE guidance on tirzepatide (TA1026) sets out the clinical criteria the medicine was assessed against, NICE TA1026 is worth reading if you want to understand what the evidence base actually says. For a broader look at how tirzepatide works and what the trial data shows, our tirzepatide overview covers that ground.
The supply of unlicensed tirzepatide into the UK follows a few routes. Some comes from compounding pharmacies in other countries, some from wholesale channels that bypass national regulators, and some is outright counterfeit. From a consumer's perspective, these look identical: a pen, a label, a price.
The risks are not identical. Unlicensed product may not have been stored correctly, tirzepatide requires refrigeration throughout the supply chain. Concentration may differ. Sterility cannot be guaranteed. And if something goes wrong, there's no clear route to report it, no pharmacovigilance trail, and no prescriber who knows you're taking it.
The MHRA's Yellow Card scheme exists so that patients and clinicians can report suspected side effects and suspect sellers. If you've come across a seller offering tirzepatide without requiring a prescription and clinical assessment, reporting it there is the right move. Our FAQs page includes guidance on spotting red flags in online weight-loss medicine sellers.
One practical note: the question of cost comes up every time this topic does. If you're comparing a Viogen-labelled price to the price of a Mounjaro prescription from a regulated pharmacy, it's worth understanding what a legitimate price actually includes, clinical assessment, prescriber review, genuine supply chain, pharmacy oversight and aftercare. Our Mounjaro cost page explains the full picture, including why prices vary between providers.
The route is straightforward. You complete a clinical consultation (online, through a service like ours) with your medical history and current weight. A GPhC-registered prescriber reads your answers personally. If tirzepatide is clinically appropriate, a prescription is issued and the medicine is dispensed from our GPhC-registered UK pharmacy through the licensed supply chain.
For those researching the broader landscape of weight-loss treatment options, it's worth knowing that tirzepatide isn't the only licensed option, but it is the most effective one available in the UK based on current trial evidence. SURMOUNT-1, published in the New England Journal of Medicine, reported around 20–21% average body-weight reduction at the 15mg dose over 72 weeks, in adults without diabetes.
Some patients ask specifically about longer-course or higher-volume supply, tirzepatide supply formats and what they mean in practice is covered separately. And if you're deciding between Mounjaro and other licensed options, this comparison page works through the differences plainly.
Orders placed by 12pm on a working day are dispatched the same day once clinically approved, worth keeping in mind if payday or a bank holiday is coming up and you want to plan ahead. If you'd like to check your eligibility and speak to our clinical team, you can start your free consultation here. Our prescribers, led by our clinical lead, review every case personally.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.